Cinchona officinalis

Cinchona officinalis, commonly known as the quinine tree, is a historic medicinal plant native to the Andean forests. Renowned for its alkaloid-rich bark, it serves as the primary natural source of quinine. This essential compound revolutionized medicine as a powerful antimalarial agent, playing a crucial role in global healthcare.

  • Scientific name: Cinchona officinalis
  • Family: Rubiaceae
  • Native range: Africa

Taxonomical Classification

This plant, Cinchona officinalis, belongs to the kingdom Plantae and the phylum Streptophyta. Within the class Equisetopsida and subclass Magnoliidae, it is classified under the order Gentianales and the family Rubiaceae. Finally, it is situated within the genus Cinchona.

Rank Classification Source
Kingdom Plantae WCVP
Phylum Streptophyta WCVP
Class Equisetopsida WCVP
Subclass Magnoliidae WCVP
Order Gentianales WCVP
Family Rubiaceae WCVP
Genus Cinchona WCVP

Common Names

This plant, known scientifically as Cinchona officinalis, is recognized by various common names across different languages and regions. In Spanish, it is referred to as Cinchona ledgeriana, while in Portuguese, it is commonly called Quinquina. Its name takes on the form Kınakına in Turkish and is identified as Κιγχόνη η φαρμακευτική in Greek. Additionally, in French, the species is known as Quinquina officinalis.
Language Common Name Source
es Cinchona ledgeriana Wikidata
pt Quinquina Wikidata
tr Kınakına Wikidata
el Κιγχόνη η φαρμακευτική Wikidata
fr Quinquina officinalis Wikidata
pt-br Quinquina Wikidata
az Dərman kinəsi Wikidata
zh 正鸡纳树 Wikidata
gl Quina Wikidata
it Cinchona calisaya Wikidata

Distribution

This plant exhibits a diverse geographical distribution spanning several continents and oceanic regions. In Western South America, it is notably found growing in Colombia. Its presence extends to the Caribbean islands, specifically within Jamaica and Puerto Rico. Moving across the ocean, the species can also be located in St. Helena in the Middle Atlantic. Finally, its range reaches West Tropical Africa, where it is documented in Guinea.

Region Area Source
West Tropical Africa Guinea WCVP
Middle Atlantic Ocean St.Helena WCVP
Caribbean Jamaica WCVP
Caribbean Puerto Rico WCVP
Western South America Colombia WCVP
Western South America Ecuador WCVP
Western South America Peru WCVP

Plant Parts

This plant, Cinchona officinalis, is highly valued in pharmacology primarily for its medicinal properties derived from its specialized tissues. The most significant parts utilized for the extraction of quinine are the bark and the stem bark. These woody layers contain high concentrations of alkaloids, which are harvested from the mature stem bark to treat conditions such as malaria. By carefully stripping the bark from the stems, practitioners can access the chemical compounds essential for therapeutic applications.
Total parts
2
Scientific sources
3
Plant Part Sources Confidence
barks 2 ★☆☆☆☆
stem bark 1 ★☆☆☆☆

Chemicals

Cinchona officinalis has 2 reported phytochemicals identified across 2 scientific publications and several other databases. The most consistently reported chemicals include cinchonine, quinine.

Total chemicals
2
Scientific sources
2

Most Reported Compounds

Compound Sources Confidence
cinchonine 1 ★☆☆☆☆
quinine 1 ★☆☆☆☆

Activities

Cinchona officinalis has 4 reported activities identified across 4 scientific publications and several other databases. The most consistently reported activities include Antibacterial, Antifungal, Antioxidant, Antiviral.

Total activities
4
Scientific sources
4

Most Reported Activities

Activity Sources Confidence
Antibacterial 1 ★☆☆☆☆
Antifungal 1 ★☆☆☆☆
Antioxidant 1 ★☆☆☆☆
Antiviral 1 ★☆☆☆☆

Medicinal Uses

Cinchona officinalis has 5 reported medicinal uses identified across 5 scientific publications and several other databases. The most consistently reported uses include COVID-19, SARS-CoV-2, central nervous system disorders, infectious disease, urinary tract infections.

Total uses
5
Scientific sources
5

Most Reported Uses

Use Sources Confidence
COVID-19 1 ★☆☆☆☆
SARS-CoV-2 1 ★☆☆☆☆
central nervous system disorders 1 ★☆☆☆☆
infectious disease 1 ★☆☆☆☆
urinary tract infections 1 ★☆☆☆☆